ArticleJournal of arrhythmia2026
R1 Prognostic Significance of T-Wave Amplitude Variability for Adverse Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
Article in Journal of arrhythmia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: T-wave amplitude variability (TAV), a marker of beat-to-beat ventricular repolarization instability, has been proposed as a potential risk marker for adverse cardiovascular outcomes, but its prognostic value remains unclear. Objectives: This meta-analysis aimed to quantitatively synthesize evidence on the association between elevated TAV and adverse cardiovascular outcomes. Methods: A systematic literature search of PubMed, Embase, and the Cochrane Library was conducted. Observational studies reporting adjusted effect estimates for the association between TAV and adverse cardiovascular outcomes were included, and separate meta-analyzes were conducted according to effect measures (hazard ratios [HRs] or odds ratios [ORs]) and exposure definition. Effect estimates were pooled using a random-effects model. Statistical heterogeneity was assessed using the Q statistic and Results: Seven studies involving 1366 patients were included. HR-based analyzes ( Conclusion: Elevated TAV is associated with an increased risk of adverse cardiovascular outcomes in HR-based analyzes, supporting its potential utility as a marker of repolarization instability for longitudinal risk stratification. In contrast, its association with ventricular tachyarrhythmias was not significant in OR-based analyzes, which showed substantial heterogeneity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.